tirofiban
美 
英
例句
The reinfarction took place in 1 AMI patient 4 days after PCI. Tirofiban was given to this patient and got a good result.
1例急性心肌梗死者于行急診PCI術后第4天發生再次梗死，應用鹽酸替羅非班癥狀緩解。
Objective: To evaluation the result of application of homemade tirofiban to 20 patients with acute coronary syndrome(ACS).
目的：評價國產鹽酸替羅非班治療急性冠脈綜合征（ACS）的有效性和安全性。
Conclusions: Intracoronary administration of tirofiban is effective and safe for ACS patients with no reflow phenomenon after PCI.
結論：冠狀動脈內注射國產鹽酸替羅非班治療ACS介入術后無復流患者是有效和安全的。
Conclusion Tirofiban to emergency intervention therapy in paitent with acute myocardial infarction is effective and safe.
結論替羅非班在急性心肌梗死的急診介入治療過程中是有效的和安全的。
Conclusion: Tirofiban can improve the situation of myocardial reperfusion after PCI in patients with STEMI .
結論：鹽酸替羅非班能明顯改善STEMI患者急診PCI后心肌組織的再灌注水平。
Conclusion: Homemade tirofiban is safety and effective in treating patients with ACS.
結論：ACS患者應用國產鹽酸替羅非班安全、有效。
The treatment in the control group was the same as that in the treatment group except that no tirofiban was infused.
對照組除未加鹽酸替羅非班外，其他治療同治療組。
Conclusion Tirofiban is effective in the patients with acute arterial embolism when accepted interventional therapy, and it is a safe drug.
結論替羅非班配合介入治療急性下肢動脈栓塞療效好，且用藥安全性較好。
The treatment in the control group was the same as that in the treatment group except the tirofiban.
對照組除未加鹽酸替羅非班外，其他治療同替羅非班組。
Methods 150 AMI patients received tirofiban during primary PCI.
方法150例AMI患者行急診PCI時聯合應用替羅非班。
Study of tirofiban used in early PCI for patients with non ST elevation acute coronary syndromes
替羅非班在非ST段抬高急性冠狀動脈綜合征早期介入治療的研究
Clinic study of domestic tirofiban during primary percutaneous coronary intervention
國產鹽酸替羅非班在急診經皮冠狀動脈介入治療中臨床應用的研究
Clinical application of tirofiban in patients with acute myocardial infarction underwent percutaneous intervention
替羅非班在急性心肌梗死介入術后患者中的臨床應用
Application of Tirofiban in Patients with Acute ST-elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
替羅非班在急性ST段抬高心肌梗死急診介入治療中的應用
Application of tirofiban in peri-primary percutaneous coronary intervention period for acute myocardial infarction patients
經驗交流替羅非班在急性心肌梗死直接支架成形術圍手術期的應用
Clinical application of tirofiban during percutaneous coronary intervention in patients with acute coronary syndrome
替羅非班在急性冠脈綜合征介入治療中的應用
Tirofiban in percutaneous coronary intervention of patients with acute non-ST segment elevation myocardial infarct: safety and efficacy
替羅非班在急性非ST段抬高心肌梗死介入治療中的安全性和有效性
Effect of tirofiban on myocardial perfusion and clinical outcomes of patients receiving direct percutaneous coronary intervention
替羅非班對直接經皮冠狀動脈介人治療患者心肌灌注及療效的影響
Application of Tirofiban in the Percutaneous Coronary Intervention or Patients with High - risk Non - ST - elevation Acute Coronary Syndrome
替羅非班在高危非ST段抬高急性冠脈綜合征患者介入治療中的應用評價
The effects of tirofiban on TIMI flow in patients with acute myocardial infarction during emergency percutaneous coronary intervention
鹽酸替羅非班對急性心肌梗死患者急診經皮冠狀動脈介入治療中TIMI血流的影響
Efficacy and safety of tirofiban in patients with acute coronary syndrome undergoing percutaneous coronary intervention
國產替羅非班治療急性冠狀動脈綜合征的臨床研究
Tirofiban in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention
國產替羅非班在高齡急性冠狀動脈綜合征患者介入治療中的應用
Application value of Tirofiban in percutaneous coronary intervention on unstable angina patients with complicated lesions
替羅非班在不穩定型心絞痛復雜病變介入治療中的應用價值
Early Impact of Tirofiban on ST-Segment Resolution and Clinical Outcomes After Primary PCI in Patients With Acute Myocardial Infarction
替羅非班對心肌梗死急診介入治療后ST段回落及臨床預后的作用
Curative Effect Assessment on the Application of Tirofiban to Patients before Coronary Bypass Grafting
冠狀動脈旁路移植患者術前應用替羅非班的臨床療效評價
Safety and risk factors related to hemorrhagic complications with tirofiban therapy in Chinese patients with acute coronary syndrome
替羅非班在急性冠脈綜合征患者中應用的安全性和出血相關因素分析
Clinical observation for using Tirofiban in acute coronary syndrome patients
國產替羅非班治療急性冠脈綜合征的臨床觀察
Treatment with Enoxaparin and Tirofiban in Acute Myocardial Infarction
急性心肌梗塞低分子量肝素與替羅非班治療研究
Clinical Investigation of Tirofiban in Treatment of Acute Coronary Syndrome
替羅非班治療急性冠脈綜合征的臨床研究
Clinical efficacy of China-made Tirofiban in patients with acute coronary syndrome undergoing PCI
國產替羅非班治療急性冠脈綜合征行PCI術患者的臨床效果
Clinical effects of tirofiban on the patients with acute coronary syndrome
替羅非班治療急性冠脈綜合征臨床觀察
Effect of Tirofiban on acute coronary syndrome patients after PCI with no reflow
替羅非班治療急性冠脈綜合征介入術后無復流的臨床研究
Effects of tirofiban on activated-platelet and prethrombotic state in rabbit iliac artery injury models
國產替羅非班對兔髂動脈損傷后血小板活化及血栓前狀態的影響
Effect of Tirofiban on Platelet Aggregation in Rabbit Thrombosis Model
替羅非班在家兔血栓模型中對血小板聚集的影響
Effect and safety of tirofiban in the treatment of acute coronary syndromes
替羅非班治療急性冠狀動脈綜合征的療效和安全性評價
The efficacy and safety of tirofiban for acute coronary syndrome
鹽酸替羅非班治療急性冠脈綜合征的研究
the left ventricular ejection fraction after PCI for 7 days was higher in tirofiban group than in verapamil group(P01) ;
替羅非班組7天后左心室射血分數高于維拉帕米組（P0.01）；
